Prevalence of Antibody Mediated Rejection in Lung Transplant Recipients with Clinical Dysfunction and/or Histological Damage: The PADOVA Experience

被引:0
|
作者
Calabrese, F. [1 ]
Vuljan, S. E. [1 ]
Lunardi, F. [1 ]
Nannini, N. [1 ]
Seveso, M. [1 ]
Loy, M. [2 ]
Ruffoni, E. [2 ]
Damin, M. [2 ]
Rigon, F. [2 ]
Cozzi, E. [2 ]
Rea, F. [1 ]
机构
[1] Univ Padua, Padua, Italy
[2] Padova Hosp, Padua, Italy
来源
关键词
D O I
10.1016/j.healun.2016.01.860
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
829
引用
收藏
页码:S301 / S301
页数:1
相关论文
共 50 条
  • [1] Evaluation of Antibody Mediated Rejection in Lung Transplant Recipients
    Bissonnette, M. L.
    Marino, S.
    Bhorade, S.
    Husain, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S43 - S44
  • [2] Evaluation of Carfilzomib for Antibody Mediated Rejection in Lung Transplant Recipients
    Pham, C.
    Pierce, B.
    Huang, H. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S81 - S81
  • [3] Age as a Predictor of Antibody Mediated Rejection in Lung Transplant Recipients: A Single-Center Experience
    Patel, M.
    Marron, R.
    Myers, C. N.
    Dorey-Stein, Z.
    Varghese, P.
    Priest, S.
    Codella, S.
    Chowdhury, J. M.
    Mills, N.
    Zhao, H.
    Shenoy, K. V.
    Criner, G. J.
    Sehgal, S.
    Mulhall, P.
    Marchetti, N.
    Galli, J.
    Cordova, F. C.
    Brown, J. C.
    Mamary, A. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] ANTIBODY-MEDIATED REJECTION IN LUNG TRANSPLANT RECIPIENTS TREATED WITH PLASMAPHERESIS
    Djordjevic, M.
    Sandhaus, T.
    Steinke, T.
    Leuze, M.
    Kirov, H.
    Faerber, G.
    Breuer, M.
    Steinert, M.
    Rummler, S.
    Doenst, T.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 11 - 12
  • [5] Plasmapheresis for the Treatment of Antibody-Mediated Rejection in Lung Transplant Recipients
    Dordevic, M.
    Sandhaus, T.
    Leuze, M.
    Steinke, T.
    Kirov, H.
    Rummler, S.
    Steinert, M.
    Faerber, G.
    Doenst, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S401 - S402
  • [6] ANTIBODY MEDIATED REJECTION THERAPY WITH BORTEZOMIB IN LUNG TRANSPLANT RECIPIENTS: A CASE SERIES
    Andreas, Fiene
    Paul, Robinson
    Adrian, Havryk
    Rebecca, Pearson
    Monique, Malouf
    Allan, Glanville
    IMMUNOLOGY AND CELL BIOLOGY, 2011, 89 (07): : A26 - A26
  • [7] A CLINICAL AUDIT OF KIDNEY TRANSPLANT RECIPIENTS WITH ANTIBODY MEDIATED REJECTION IN SOUTHERN TASMANIA
    Patel, B.
    Nejatian, A.
    Skeat, L.
    Kirkland, G.
    Jose, M.
    NEPHROLOGY, 2020, 25 : 79 - 79
  • [8] Antibody Mediated Rejection in Pediatric Heart Transplant Recipients
    Frandsen, E. L.
    Gimferrer, I.
    Rudzinski, E. R.
    Ahmed, H.
    Albers, E. A.
    Friedland-Little, J. M.
    Hong, B. J.
    Kemna, M. S.
    Newland, D. M.
    Law, Y. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S500 - S500
  • [9] Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
    Pham, Christine
    Pierce, Brett J.
    Nguyen, Duc T.
    Graviss, Edward A.
    Huang, Howard J.
    TRANSPLANTATION DIRECT, 2021, 7 (04): : E680
  • [10] Antibody-mediated lung transplant rejection
    Ramsey Hachem
    Current Respiratory Care Reports, 2012, 1 (3): : 157 - 161